Strong expression of FGFR2 was observed in less than 5% of AK samples. In cSCC and metastatic cSCC, cytoplasmic and perinuclear FGFR2 was noted in tumor cells in the invasive margin and expression was predominantly strong (55% and 60%, respectively). Here, FGFR2 is linked to neoplasm.